Sulfuric Acid

Sulfuric Acid

SCHEMBL6515066

CCn1c(=NN=c2sc3ccccc3n2CC)sc2ccccc21.O=S(=O)(O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
NPSR1 Q6W5P4 3/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPK1 P28482 1/20 0.55
KCNQ3 O43525 1/20 0.55
KCNQ2 O43526 1/20 0.55
LMNA P02545 2/20 0.47
CNR1 P21554 3/20 0.45
CNR2 P34972 3/20 0.45
KMT2A Q03164 3/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.42
HIF1A Q16665 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL2532781 1.00 TSHR (0.55) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL893600 0.91 ALDH1A1 (0.56) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL29387616 0.91 ALDH1A1 (0.56) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL4725543 0.89 ALDH1A1 (0.49) TSHRNPSR1ALDH1A1MAPK1KCNQ3
Ammonia Solution, Strong SCHEMBL8555602 0.88 ALDH1A1 (0.48) TSHRNPSR1ALDH1A1MAPK1KCNQ3
Phosphoric Acid SCHEMBL6538345 0.88 TSHR (0.55) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL1679319 0.87 ALDH1A1 (0.47) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL18785100 0.87 ALDH1A1 (0.47) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL15849845 0.87 ALDH1A1 (0.47) TSHRNPSR1ALDH1A1MAPK1KCNQ3
SCHEMBL9305445 0.84 ALDH1A1 (0.45) TSHRNPSR1ALDH1A1MAPK1KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353822-A1 Immunoenzymatic single-plate elisa method with competitive inhibitition for detecting antisporozoite antibodies of plasmodium falciparum ENIRICERCHE S.p.A. (IT) 1990-02-07 EP claimed
US-20050058636-A1 Medicament against thrombotic diseases ZLB BEHRING GMBH (DE) 2005-03-17 US disclosed
EP-1344532-A1 High molecular weight kininogen (HK) domain 5 derived peptides against thrombic diseases Aventis Behring GmbH (DE) 2003-09-17 EP disclosed
EP-1344531-A1 High molecular weight kininogen (HK) domain 5 derived peptides against thrombic diseases Aventis Behring GmbH (DE) 2003-09-17 EP disclosed
WO-2002076477-A1 SKIN-TEST REAGENTS AND SERUM SPECIFIC IGE, IGG SUBTYPES DETECTION KITS, COMPRISING CRUDE EXTRACTS OF SPIDER MITES SUCH AS CITRUS RED MITE, TWO-SPOTTED SPIDER MITE AND EUROPEAN RED MITE BIOALLETECH CO., LTD. (KR) 2002-10-03 WO disclosed
US-5962404-A CENTRAL NERVOUS SYSTEM DISORDERS YEDA RESEARCH & DEVELOPMENT CO., LTD. (IL) 1999-10-05 US disclosed
EP-0415321-B1 Oligodendrocyte cytotoxic factor YEDA RES & DEV (IL) 1995-11-08 EP disclosed
US-5459079-A Support for biologically active molecules which itself may be biologically active, process for its preparation and its biological applications RHONE-POULENC CHIMIE (FR) 1995-10-17 US disclosed
EP-0415321-A1 Oligodendrocyte cytotoxic factor YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) 1991-03-06 EP disclosed